Mature T-Cell and NK-Cell Neoplasm — Trials

Mature T-Cell and NK-Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

825 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 101–150 of 162 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02243579	Pembrolizumab in Treating Patients With Relapsed or Refractory Stage IB-IVB Mycosis Fungoides or Sezary Syndrome	completed	Phase 2	24	National Cancer Institute (NCI)NIH	1	Sep 20, 2019	clinicaltrials
NCT01676831	Topical Resiquimod for the Treatment of Early Stage Cutaneous T Cell Lymphoma (CTCL)	completed	Phase 1 / Phase 2	13	Abramson Cancer Center at Penn MedicineOTHER	1	Aug 13, 2019	clinicaltrials